Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
29%
OVERLAP
BY WEIGHT
9
# OF OVERLAPPING
HOLDINGS
PPH
26
HOLDINGS
39%
ALSO IN PJP
PJP
29
HOLDINGS
31%
ALSO IN PPH
SECTOR DRIFT (PPH minus PJP)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PPH |
Weight in PJP |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 18.8% | 5.2% | 5.2% |
|
MERCK & CO. INC. | 6.1% | 5.1% | 5.1% |
|
JOHNSON & JOHNSON | 10.3% | 4.9% | 4.9% |
|
PFIZER INC | 4.8% | 5.2% | 4.8% |
|
ABBVIE INC | 4.6% | 4.9% | 4.6% |
PPH Overweight Relative to PJP
|
ELI LILLY & CO | 13.6% |
 |
NOVARTIS AG-ADR | 7.6% |
 |
NOVO-NORDISK A/S-SPONS ADR | 7.5% |
|
JOHNSON & JOHNSON | 5.4% |
|
MCKESSON CORP | 4.6% |
 |
SANOFI-AVENTIS-ADR | 4.5% |
 |
ASTRAZENECA PLC-SPONS ADR | 4.5% |
|
ZOETIS INC | 4.3% |
|
GLAXOSMITHKLINE PLC-SPON ADR | 4.2% |
|
CENCORA INC | 3.8% |
PPH Underweight Relative to PJP
|
AMGEN INC | -5.0% |
|
GILEAD SCIENCES INC | -4.8% |
|
ABBOTT LABORATORIES | -4.7% |
|
OCULAR THERAPEUTIX INC | -4.1% |
|
LIGAND PHARMACEUTICALS-CL B | -3.1% |
|
AMNEAL PHARMACEUTICALS, INC. CLASS A | -3.0% |
|
BIOSANTE PHARMACEUTICALS INC | -2.9% |
|
COLLEGIUM PHARMACEUTICAL, INC. | -2.9% |
|
TRAVERE THERAPEUTICS, INC. | -2.8% |
|
BIOGEN IDEC INC | -2.7% |